Vancouver, British Columbia, January 11, 2021 – Beyond Medical Technologies Inc. (“Beyond Medical” or the “Company”) (CSE: DOCT, Frankfurt: 7FM3) is pleased to announce that is has granted an aggregate of 5,000,000 stock options (the “Options”) to directors, officers, employees, and consultants of the Company to purchase 5,000,000 common shares (the “Shares”) in the capital of the Company pursuant to the Company’s share option plan. The Options, which vest immediately, are exercisable at an exercise price of $0.075 per Share for a period of five (5) years from the date of grant.
About Beyond Medical
Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. The Company, through its subsidiary Micron Technologies, manufactures medical grade face masks. The Company also has an investment in digital telehealth platform in Kayan Health. Kayan Health is an artificial-intelligence powered health communications platform that allows doctors to communicate with their patients and monitor them remotely. https://kayanhealth.com
Kal Malhi, CEO
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.
The securities of the Company referred to in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.
© 2021 Beyond Medical Technologies Inc.